Oak Ridge Investments’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.4M Buy
91,644
+912
+1% +$63.7K 0.46% 44
2025
Q1
$6.67M Sell
90,732
-53,241
-37% -$3.91M 0.55% 39
2024
Q4
$9.43M Buy
143,973
+7,341
+5% +$481K 0.74% 29
2024
Q3
$10.6M Buy
136,632
+9,141
+7% +$712K 0.93% 23
2024
Q2
$9.94M Buy
127,491
+5,887
+5% +$459K 0.95% 21
2024
Q1
$8.24M Buy
121,604
+5,286
+5% +$358K 0.83% 28
2023
Q4
$7.83M Buy
116,318
+927
+0.8% +$62.4K 0.9% 23
2023
Q3
$7.81M Buy
115,391
+2,647
+2% +$179K 1% 23
2023
Q2
$8.07M Sell
112,744
-856
-0.8% -$61.3K 1% 20
2023
Q1
$7.88M Sell
113,600
-646
-0.6% -$44.8K 1.07% 15
2022
Q4
$7.75M Buy
114,246
+39
+0% +$2.64K 1.15% 16
2022
Q3
$6.26M Buy
114,207
+6,396
+6% +$351K 0.95% 21
2022
Q2
$7.12M Buy
107,811
+47,758
+80% +$3.16M 1.04% 17
2022
Q1
$3.98M Sell
60,053
-7,326
-11% -$486K 0.44% 70
2021
Q4
$3.92M Buy
67,379
+8,735
+15% +$509K 0.33% 90
2021
Q3
$3.52M Buy
+58,644
New +$3.52M 0.31% 101